MGNet Administrative Core
MGNet Administrative Core
批准号:
10645044
负责人:
HENRY J KAMINSKI
金额:
$103.22万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2024-05-31
关键词:
AdvertisingAwardBiometryClinicalClinical ResearchClinical TrialsClinical and Translational Science AwardsCollaborationsData AnalysesDevelopmentDrug IndustryEducationFinancial SupportFoundationsGeneral HospitalsGoalsHealth ProfessionalImmunologicsImmunologistIndividualIndustryInformation DisseminationInfrastructureInstitutional Review BoardsInternationalInvestigationLeadershipManuscriptsMassachusettsMissionMuscular DystrophiesMyasthenia GravisNorth CarolinaOutcome MeasurePatient CarePatient advocacyPatientsPerformancePharmacologic SubstancePilot ProjectsPreparationProcessProgress ReportsRare DiseasesRecording of previous eventsResearchResearch Project GrantsResourcesScientistServicesSiteStrategic PlanningStructureTherapeuticTrainingUniversitiesValidationVirginiaWashingtoncareerclinical centerclinical trial readinessdata sharingimprovedindustry partnerinfrastructure developmentinterestmeetingsmembernovel therapeuticspatient advocacy grouppaymentpredictive markerprocess improvementprogramsrecruitsuccesstherapeutic developmenttranslational scientistweb site
中文摘要
MGNet的管理核心用于支持RDCRN的所有活动,以优化
临床研究绩效和职业提升活动。我们通过提供工作人员来做到这一点。
专注于促进与学习开始、执行和结束相关的所有活动
活动。临床研究协调员培训、生物统计分析、临床
将提供试验开发和免疫学调查。MGNet的领导力
包括行政协调员、临床医生、翻译科学家、免疫学家、患者
倡导团体领导层和患者。该协作小组将提供监督和
推动流程改进并制定战略计划,以确保长期的可行性
MGNet的一部分。管理核心将在目前的基础上开发重点项目
建议在MGNet网站之外加强临床试验准备,并与业界合作以
优化MG临床试验绩效。MGNet所有成员的共同目标是1)
提供一种结构以加强对治疗反应的发现和验证,或-
以促进治疗发展为最终目标的预测标记物,2)改进
临床试验结果衡量标准和基础设施,以及3)提高临床质量
为MG做研究。随着MGNet的成熟,
英文摘要
The Administrative Core of MGNet serves to support all activities of the RDCRN to optimize
clinical research performance and career enhancement activities. We do so by provision of staff
focused on facilitation of all activities related to study initiation, performance, and close out
activities. Core services for clinical research coordinator training, biostatistical analysis, clinical
trial development, and immunological investigations will be provided. The leadership of MGNet
includes the administrative coordinator, clinicians, translational scientists, immunologists, patient
advocacy group leadership, and patients. This collaborative group will provide oversight and
drive process improvement as well as develop a strategic plan to assure the long-term viability
of MGNet. Administrative Core will develop focused projects beyond those in the present
proposal to enhance clinical trial readiness beyond MGNet sites and partner with industry to
optimize the performance of MG clinical trials. The shared goals of all members of MGNet are 1)
to provide a structure to enhance discovery and validation of treatment-responsive or –
predictive markers with the ultimate goal of enhancing therapeutic development, 2) improve
clinical trial outcome measures and infrastructure, and 3) enhance the quality of clinical
research for MG. As MGNet matures, the
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MGNet Administrative Core
-
批准号:10437795
-
项目类别:
-
资助金额:$100.65万
-
财政年份:2019
-
负责人:HENRY J KAMINSKI
-
依托单位:
Rare Disease Network for Myasthenia Gravis
-
批准号:10207810
-
项目类别:
-
资助金额:$149.07万
-
财政年份:2019
-
负责人:HENRY J KAMINSKI
-
依托单位:
Rare Disease Network for Myasthenia Gravis
-
批准号:10437794
-
项目类别:
-
资助金额:$158.9万
-
财政年份:2019
-
负责人:HENRY J KAMINSKI
-
依托单位:
An Open Label Trial of Ixazomib for Treatment Resistant Myasthenia Gravis
-
批准号:10437798
-
项目类别:
-
资助金额:$24.72万
-
财政年份:2019
-
负责人:HENRY J KAMINSKI
-
依托单位:
Rare Disease Network for Myasthenia Gravis
-
批准号:9804343
-
项目类别:
-
资助金额:$161.02万
-
财政年份:2019
-
负责人:HENRY J KAMINSKI
-
依托单位:
Rare Disease Network for Myasthenia Gravis
-
批准号:10005504
-
项目类别:
-
资助金额:$153.16万
-
财政年份:2019
-
负责人:HENRY J KAMINSKI
-
依托单位:
Rare Disease Network for Myasthenia Gravis
-
批准号:10645043
-
项目类别:
-
资助金额:$153.44万
-
财政年份:2019
-
负责人:HENRY J KAMINSKI
-
依托单位:
An Open Label Trial of Ixazomib for Treatment Resistant Myasthenia Gravis
-
批准号:10645048
-
项目类别:
-
资助金额:$15.79万
-
财政年份:2019
-
负责人:HENRY J KAMINSKI
-
依托单位:
An Open Label Trial of Ixazomib for Treatment Resistant Myasthenia Gravis
-
批准号:10207813
-
项目类别:
-
资助金额:$22.27万
-
财政年份:2019
-
负责人:HENRY J KAMINSKI
-
依托单位:
MGNet Administrative Core
-
批准号:10207811
-
项目类别:
-
资助金额:$94.96万
-
财政年份:2019
-
负责人:HENRY J KAMINSKI
-
依托单位:
Targeted Therapy for Myasthenia Gravis
-
批准号:10004729
-
项目类别:
-
资助金额:$23.28万
-
财政年份:2019
-
负责人:HENRY J KAMINSKI
-
依托单位:
Regulation of Extraocular Muscle Development
-
批准号:7446465
-
项目类别:
-
资助金额:$21.99万
-
财政年份:2004
-
负责人:HENRY J KAMINSKI
-
依托单位:
Regulation of Extraocular Muscle Development
-
批准号:6844605
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2004
-
负责人:HENRY J KAMINSKI
-
依托单位:
Regulation of Extraocular Muscle Development
-
批准号:7060809
-
项目类别:
-
资助金额:$36.86万
-
财政年份:2004
-
负责人:HENRY J KAMINSKI
-
依托单位:
Regulation of Extraocular Muscle Development
-
批准号:7177461
-
项目类别:
-
资助金额:$14.66万
-
财政年份:2004
-
负责人:HENRY J KAMINSKI
-
依托单位:
Targeted Therapies for Myasthenia Gravis
-
批准号:6945146
-
项目类别:
-
资助金额:$82.62万
-
财政年份:2003
-
负责人:HENRY J KAMINSKI
-
依托单位:
Targeted Therapies for Myasthenia Gravis
-
批准号:7287393
-
项目类别:
-
资助金额:$101.89万
-
财政年份:2003
-
负责人:HENRY J KAMINSKI
-
依托单位:
Targeted Therapies for Myasthenia Gravis
-
批准号:6670039
-
项目类别:
-
资助金额:$85.09万
-
财政年份:2003
-
负责人:HENRY J KAMINSKI
-
依托单位:
Targeted Therapies for Myasthenia Gravis
-
批准号:7123807
-
项目类别:
-
资助金额:$123.45万
-
财政年份:2003
-
负责人:HENRY J KAMINSKI
-
依托单位:
Targeted Therapies for Myasthenia Gravis
-
批准号:6805691
-
项目类别:
-
资助金额:$87.26万
-
财政年份:2003
-
负责人:HENRY J KAMINSKI
-
依托单位:
海外基金